Karyopharm Therapeutics reported $34.64M in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbott ABT:US USD 2.83B 98M
Abbvie ABBV:US USD 3.22B 86M
Amgen AMGN:US USD 1.47B 181M
AstraZeneca AZN:LN USD 3.35B 280M
Astrazeneca AZN:US USD 3.35B 280M
Avrobio Inc AVRO:US USD 7.07M 1.83M
Biocryst Pharmaceuticals BCRX:US USD 36.92M 1.1M
Bristol Myers Squibb BMY:US USD 2.27B 336M
Eli Lilly And LLY:US USD 1.64B 29M
Enanta Pharmaceuticals ENTA:US USD 12.57M 360K
GlaxoSmithKline GSK:LN GBP 2.44B 467M
Johnson & Johnson JNJ:US USD 6.51B 423M
Karyopharm Therapeutics KPTI:US USD 34.64M 2.69M
Macrogenics MGNX:US USD 15.35M 1.69M
Merk MRK:US USD 2.63B 134M
Mirati Therapeutics MRTX:US USD 60.8M 6.57M
Nektar Therapeutics NKTR:US USD 22.53M 1.09M
Novartis NOVN:VX USD 3.4B 185M
Novartis NVS:US USD 3.7B 295M
Pfizer PFE:US USD 4.87B 1.33B
Regeneron Pharmaceuticals REGN:US USD 660.5M 131.4M
Roche Holding ROG:VX 5.64B 899M
Sangamo Biosciences SGMO:US USD 16.24M 1.14M
Takeda 4502:JP JPY 262.3B 13.57B
Tg Therapeutics TGTX:US USD 14.25M 1.62M
Ultragenyx Pharmaceutical RARE:US USD 69.84M 1.7M
Xencor XNCR:US USD 12.37M 1.28M
YTE INCY:US USD 266.46M 13.18M